 therapy. Treatment of extracranial
disease offers the potential advantages of preventing further
embolization from the extracranial carotid atherosclerosis,
increasing perfusion to the ischemic penumbra surrounding the area of cerebral infarct, enhancing arterial flow to
augment clot-dissolution therapies, improve access for intervention on the intracranial lesions, and potentially improve the patency of the intracranial intervention. The use
of CAS as